Literature DB >> 25677904

Apoptosis induced by chamaejasmine in human osteosarcoma cells through p53 pathway.

Dawei Yang1, Peng Wang, Xiaoping Ren.   

Abstract

Osteosarcoma cancer is one of the most lethal malignancies, and there is no effective preventive measure to date. Chamaejasmine is the major ingredient in Stellera chamaejasme L. Except its potent pain-relieving efficacy as reported, chamaejasmine also exerted its anti-tumor activity in several tumor models. Here, we reported that chamaejasmine had a profound anti-proliferative effect on human osteosarcoma cells in a concentration-dependent and time-dependent manner, which was associated with an increase of p21 and bax and a decrease of bcl-2 and consequently increased caspase-3 activity. The main mechanism of anti-tumor potency was mainly attributed to the induction of p53. Chamaejasmine hugely elevated the expression of p53. The results of p53 shRNA experiment further demonstrated that p53 knockdown severely impaired the sensitivity of tested cells to chamaejasmine, implicating the important role of p53 played in chamaejasmine's anti-tumor activity. In conclusion, results showed chamaejasmine induced apoptosis in MG63 cells and could be a candidate drug for osteosarcoma cancer chemoprevention.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25677904     DOI: 10.1007/s13277-015-3209-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  22 in total

Review 1.  The future of sarcoma treatment.

Authors:  J S Biermann; L H Baker
Journal:  Semin Oncol       Date:  1997-10       Impact factor: 4.929

Review 2.  p21Cip1/Waf1 protein and its function based on a subcellular localization [corrected].

Authors:  Jana Cmielová; M Rezáčová
Journal:  J Cell Biochem       Date:  2011-12       Impact factor: 4.429

3.  Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis.

Authors:  M Los; M Van de Craen; L C Penning; H Schenk; M Westendorp; P A Baeuerle; W Dröge; P H Krammer; W Fiers; K Schulze-Osthoff
Journal:  Nature       Date:  1995-05-04       Impact factor: 49.962

4.  Overexpression of Bax gene sensitizes K562 erythroleukemia cells to apoptosis induced by selective chemotherapeutic agents.

Authors:  T Kobayashi; S Ruan; K Clodi; K O Kliche; H Shiku; M Andreeff; W Zhang
Journal:  Oncogene       Date:  1998-03-26       Impact factor: 9.867

Review 5.  Osteosarcoma: review of the past, impact on the future. The American experience.

Authors:  Norman Jaffe
Journal:  Cancer Treat Res       Date:  2009

Review 6.  Osteosarcoma. Specific tumor management and results.

Authors:  M P La Quaglia
Journal:  Chest Surg Clin N Am       Date:  1998-02

Review 7.  Current treatment of osteosarcoma.

Authors:  W S Ferguson; A M Goorin
Journal:  Cancer Invest       Date:  2001       Impact factor: 2.176

8.  Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis.

Authors:  D W Nicholson; A Ali; N A Thornberry; J P Vaillancourt; C K Ding; M Gallant; Y Gareau; P R Griffin; M Labelle; Y A Lazebnik
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

Review 9.  Adjuvant and neoadjuvant chemotherapy in osteosarcoma.

Authors:  G Bacci; S Lari
Journal:  Chir Organi Mov       Date:  2001 Oct-Dec

10.  Chamaejasmine inactivates Akt to trigger apoptosis in human HEp-2 larynx carcinoma cells.

Authors:  Yu Wang; Yan Zhao; Ying Liu; Linli Tian; Dejun Jin
Journal:  Molecules       Date:  2011-09-27       Impact factor: 4.411

View more
  8 in total

Review 1.  Anticancer Effects of Constituents of Herbs Targeting Osteosarcoma.

Authors:  Qing-Hong Su; Xiao-Qun Xu; Jun-Fu Wang; Jun-Wen Luan; Xia Ren; Hai-Yan Huang; Si-Shan Bian
Journal:  Chin J Integr Med       Date:  2019-06-04       Impact factor: 1.978

2.  ESC reverses epithelial mesenchymal transition induced by transforming growth factor-β via inhibition of Smad signal pathway in HepG2 liver cancer cells.

Authors:  Xiao-Ni Liu; Shuang Wang; Qing Yang; Ya-Jie Wang; De-Xi Chen; Xiao-Xin Zhu
Journal:  Cancer Cell Int       Date:  2015-12-10       Impact factor: 5.722

Review 3.  Development of Certain Protein Kinase Inhibitors with the Components from Traditional Chinese Medicine.

Authors:  Minghua Liu; Ge Zhao; Shousong Cao; Yangyang Zhang; Xiaofang Li; Xiukun Lin
Journal:  Front Pharmacol       Date:  2017-01-09       Impact factor: 5.810

4.  Identification of Key Genes Affecting Results of Hyperthermia in Osteosarcoma Based on Integrative ChIP-Seq/TargetScan Analysis.

Authors:  Yuxia Shi; Fan Yang; Shuqing Wei; Gang Xu
Journal:  Med Sci Monit       Date:  2017-04-28

5.  The role of chamaejasmine in cellular apoptosis and autophagy in MG-63 cells.

Authors:  Dawei Yang; Hao Zhang; Jianjun Wu; Ruishuang Ma; Zongyu Li; Kunzheng Wang; Fan Yang
Journal:  Biosci Rep       Date:  2019-01-15       Impact factor: 3.840

6.  A 10-year bibliometric analysis of osteosarcoma and cure from 2010 to 2019.

Authors:  Wacili Da; Zhengbo Tao; Yan Meng; Kaicheng Wen; Siming Zhou; Keda Yang; Lin Tao
Journal:  BMC Cancer       Date:  2021-02-04       Impact factor: 4.430

7.  Stellera chamaejasme L. extracts in the treatment of glioblastoma cell lines: Biological verification based on a network pharmacology approach.

Authors:  Kaiyue Wang; Zengyong Wang; Zhiqiang Wang; Xiaoli Xie; Lanlan Zang; Lijuan Wang; Fengyuan Che
Journal:  Front Oncol       Date:  2022-08-17       Impact factor: 5.738

8.  Neochamaejasmin A Induces Mitochondrial-Mediated Apoptosis in Human Hepatoma Cells via ROS-Dependent Activation of the ERK1/2/JNK Signaling Pathway.

Authors:  Yangfang Ding; Qi Xie; Wenjing Liu; Zhaohai Pan; Xinmei Fan; Xiaoyu Chen; Mingkai Li; Wei Zhao; Defang Li; Qiusheng Zheng
Journal:  Oxid Med Cell Longev       Date:  2020-01-20       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.